(VIANEWS) – Shares of Sorrento Therapeutics (NASDAQ Composite: SRNE) slid 5.42% to $6.38 at 13:19 EST on Wednesday, following the last session’s upward trend. NASDAQ Composite is sliding 0.07% to $15,118.81, after five successive sessions in a row of gains. This seems, up to now, a somewhat negative trend trading session today.

Sorrento Therapeutics’s last close was $6.74, 60.93% below its 52-week high of $17.25.


Today’s last reported volume for Sorrento Therapeutics is 3585886 which is 24.08% below its average volume of 4723653.

Sorrento Therapeutics’s Sales

Sorrento Therapeutics’s sales growth is a negative 13.4% for the ongoing quarter and 13% for the next. The company’s growth estimates for the ongoing quarter and the next is 30.3% and 14.8%, respectively.

Sorrento Therapeutics’s Revenue

Year-on-year quarterly revenue growth grew by 84.6%, now sitting on 46.52M for the twelve trailing months.


Sorrento Therapeutics’s last week, last month’s, and last quarter’s current volatility was a positive 0.11%, a negative 1.82%, and a positive 2.86%, respectively.

Sorrento Therapeutics’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.99% (last week), 3.49% (last month), and 2.86% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Sorrento Therapeutics’s stock is considered to be overbought (>=80).

Sorrento Therapeutics’s Stock Yearly Top and Bottom Value

Sorrento Therapeutics’s stock is valued at $6.38 at 13:19 EST, way under its 52-week high of $17.25 and way above its 52-week low of $5.17.

Sorrento Therapeutics’s Moving Average

Sorrento Therapeutics’s value is way below its 50-day moving average of $7.57 and way below its 200-day moving average of $8.07.

More news about Sorrento Therapeutics (SRNE).


Please enter your comment!
Please enter your name here